Tumor response to neoadjuvant chemoradiation therapy for rectal adenocarcinoma is mediated by p53-dependent and caspase 8-dependent apoptotic pathways.

Clinical colorectal cancer

Volumn 5, Issue 2, 2005, Pages 114-118

  Kelley, Scott T ^a   Coppola, Domenico ^a   Yeatman, Timothy ^a   Marcet, Jorge ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; BIOLOGICAL MARKER; CASP8 PROTEIN, HUMAN; CASPASE; CASPASE 8; FLUOROURACIL; PROTEIN P53;

ADENOCARCINOMA; ADJUVANT THERAPY; AGED; APOPTOSIS; ARTICLE; FEMALE; GENETIC TRANSCRIPTION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; RADIATION DOSE; RECTUM TUMOR; RETROSPECTIVE STUDY;

ADENOCARCINOMA; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BIOLOGICAL MARKERS; CASPASE 8; CASPASES; FEMALE; FLUOROURACIL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PREDICTIVE VALUE OF TESTS; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33644833530     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2005.n.023     Document Type: Article

References (0)